← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2020Last known activity
Oct 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT07138625Lead sponsorN/AOct 1, 2025
- NCT07138625Sponsor investigatorN/AOct 1, 2025
- NCT07121634Sponsor investigatorN/AJan 1, 2024
- NCT07121634Lead sponsorN/AJan 1, 2024
- NCT06639711Sponsor investigatorPhase 1/Phase 2Jul 10, 2023
- NCT06639711Lead sponsorPhase 1/Phase 2Jul 10, 2023
- NCT04569825Reponsible party - principal investigatorEarly Phase 1Aug 1, 2020
- NCT04569825Overall official - principal investigatorEarly Phase 1Aug 1, 2020
- NCT04569825Lead sponsorEarly Phase 1Aug 1, 2020
Details
- Last known activity
- Oct 1, 2025